Rep. Julie Johnson Sells Off Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Representative Julie Johnson (D-Texas) recently sold shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA). In a filing disclosed on March 12th, the Representative disclosed that they had sold between $1,001 and $15,000 in Walgreens Boots Alliance stock on February 12th. The trade occurred in the Representative’s “MERRILL LYNCH TAX EFFICIENT CORE” account.

Representative Julie Johnson also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Norfolk Southern (NYSE:NSC) on 2/25/2025.
• Purchased $1,001 – $15,000 in shares of Union Pacific (NYSE:UNP) on 2/25/2025.
• Purchased $1,001 – $15,000 in shares of Bank of New York Mellon (NYSE:BK) on 2/24/2025.
• Sold $1,001 – $15,000 in shares of BlackRock (NYSE:BLK) on 2/24/2025.
• Sold $1,001 – $15,000 in shares of The PNC Financial Services Group (NYSE:PNC) on 2/24/2025.
• Purchased $1,001 – $15,000 in shares of Progressive (NYSE:PGR) on 2/24/2025.
• Purchased $1,001 – $15,000 in shares of The Goldman Sachs Group (NYSE:GS) on 2/24/2025.
• Purchased $1,001 – $15,000 in shares of Capital One Financial (NYSE:COF) on 2/24/2025.
• Purchased $1,001 – $15,000 in shares of Capital One Financial (NYSE:COF) on 2/14/2025.
• Purchased $1,001 – $15,000 in shares of Progressive (NYSE:PGR) on 2/14/2025.

Walgreens Boots Alliance Price Performance

Shares of NASDAQ WBA opened at $11.26 on Friday. Walgreens Boots Alliance, Inc. has a twelve month low of $8.08 and a twelve month high of $22.05. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68. The firm has a 50-day moving average of $10.79 and a two-hundred day moving average of $9.75. The company has a market capitalization of $9.73 billion, a price-to-earnings ratio of -1.10, a PEG ratio of 1.31 and a beta of 0.62.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, beating the consensus estimate of $0.38 by $0.13. The business had revenue of $39.50 billion during the quarter, compared to analyst estimates of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The business’s quarterly revenue was up 7.6% on a year-over-year basis. During the same period in the prior year, the business earned $0.66 earnings per share. As a group, analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on the company. Truist Financial decreased their target price on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a report on Friday, January 31st. Royal Bank of Canada lifted their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a research note on Wednesday, January 15th. Wolfe Research upgraded Walgreens Boots Alliance to a “hold” rating in a report on Monday, February 24th. Deutsche Bank Aktiengesellschaft cut shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating and decreased their target price for the stock from $11.00 to $9.00 in a report on Friday, February 28th. Finally, Bank of America boosted their price target on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a report on Monday, January 13th. Four equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $11.54.

Institutional Investors Weigh In On Walgreens Boots Alliance

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in WBA. First Financial Corp IN increased its stake in shares of Walgreens Boots Alliance by 49.2% in the fourth quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock worth $25,000 after acquiring an additional 885 shares during the last quarter. Golden State Wealth Management LLC purchased a new position in Walgreens Boots Alliance in the fourth quarter valued at about $26,000. Riverview Trust Co increased its position in Walgreens Boots Alliance by 123.8% in the 4th quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator’s stock worth $27,000 after purchasing an additional 1,590 shares during the last quarter. Colonial Trust Co SC raised its stake in shares of Walgreens Boots Alliance by 79.5% during the 4th quarter. Colonial Trust Co SC now owns 2,928 shares of the pharmacy operator’s stock worth $27,000 after purchasing an additional 1,297 shares in the last quarter. Finally, Venturi Wealth Management LLC acquired a new stake in shares of Walgreens Boots Alliance during the 4th quarter valued at about $28,000. Hedge funds and other institutional investors own 58.59% of the company’s stock.

About Representative Johnson

Julie Johnson (Democratic Party) is a member of the U.S. House, representing Texas’ 32nd Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027.

Johnson (Democratic Party) ran for election to the U.S. House to represent Texas’ 32nd Congressional District. She won in the general election on November 5, 2024.

Julie Johnson earned a B.A. in history and government from the University of Texas at Austin in 1987 and a J.D. from the University of Houston Law Center in 1991. Johnson’s career experience includes working as an attorney.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.